Lv1
100 积分 2024-12-06 加入
Response to Osimertinib in a Patient With Non-Small Cell Lung Cancer and Two Uncommon EGFR mutations
4个月前
已关闭
Osimertinib plus consolidative radiotherapy for advanced EGFR mutant non–small cell lung cancer: a multicentre, single-arm, phase 2 trial
4个月前
已完结
Ophthalmic Immune-Related Adverse Events and Association with Survival: Results from a Real-World Database
7个月前
已完结
Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer
9个月前
已完结
Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro
9个月前
已完结
皖公网安备34019202002308
